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Mutations in SPINT2 encoding the epithelial serine protease inhibitor hepatocyte growth
factor activator inhibitor-2 (HAI-2) are associated with congenital tufting enteropathy.
However, the functions of HAI-2 in vivo are poorly understood. Here we used tamoxifen-
induced Cre-LoxP recombination in mice to ablate Spint2. Mice lacking Spint2 died within
6 days after initiating tamoxifen treatment and showed severe epithelial damage in the whole
intestinal tracts, and, to a lesser extent, the extrahepatic bile duct. The intestinal epithelium
showed enhanced exfoliation, villous atrophy, enterocyte tufts and elongated crypts. Orga-
noid crypt culture indicated that Spint2 ablation induced Epcam cleavage with decreased
claudin-7 levels and resulted in organoid rupture. These organoid changes could be rescued
by addition of serine protease inhibitors aprotinin, camostat mesilate and matriptase-
selective α-ketobenzothiazole as well as by co-deletion of Prss8, encoding the serine protease
prostasin. These results indicate that HAI-2 is an essential cellular inhibitor for maintaining
intestinal epithelium architecture.
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SPINT2 encodes the type 1 transmembrane protein hepato-cyte growth factor activator inhibitor (HAI)-2 that has twoextracellular Kunitz-type serine protease inhibitor domains,
namely KD1 (N-terminal side Kunitz domain) and KD2
(C-terminal side Kunitz domain), a single path transmembrane
domain and a short intracytoplasmic domain1,2. The protease
inhibitor domain of HAI-2 is homologous to that of HAI-1.
HAI-2 and HAI-1 also have a similar anti-protease spectrum and
are frequently co-expressed by epithelial cells. They regulate the
activities of serum hepatocyte growth factor activator (HGFA),
cellular type 2 transmembrane serine proteases (TTSP), particu-
larly matriptase, and glycosylphosphatidylinositol-anchored ser-
ine protease, Prss8 (also known as prostasin)1,3–5. However, in a
human cell line expressing both HAI-1 and HAI-2, HAI-2 could
not compensate for loss of HAI-1 and vice versa, and silencing of
SPINT1 or SPINT2 produces speciﬁc and differing phenotypes,
suggesting that these two protease inhibitors have distinct roles in
epithelial cells1,6,7. Indeed, HAI-1 has a distinct cell surface
localization, whereas HAI-2 localizes to the cytoplasm8–10. In
mice, deletion of either Spint1 or Spint2 produces an embryonic
lethal phenotype, also indicating that Hai-2 does not compensate
for loss of Hai-1 and vice versa in vivo11,12.
Mutations in the SPINT2 gene cause a syndromic form of
congenital sodium diarrhea (CSD), a rare autosomal-recessive
disorder that occurs during infancy13, suggesting a fundamental
role for HAI-2 in the function of intestinal mucosa. Syndromic
CSD is associated with choanal or anal atresia, hypertelorism, and
corneal erosions. Five distinct mutations of the SPINT2 gene have
been reported for syndromic CSD, and the mutations associated
with this disease result in either reduced protease inhibitor
activity of HAI-2 or loss of HAI-2 synthesis13–15. Notably, a
single amino acid mutation in KD2 (Y163C) is sufﬁcient to
induce syndromic CSD, suggesting that KD2 is critical for HAI-2
function in the intestine. For histopathological classiﬁcation,
SPINT2 mutation-related enteropathy is classiﬁed as congenital
tufted enteropathy (CTE), characterized by villous atrophy and
focal crowding at the villus tips due to disorganization of
enterocytes15,16. Given that conventional CTE is caused by
mutations in the EPCAM gene that encodes epithelial cell adhe-
sion molecule (EpCAM)15, SPINT2 mutation-induced entero-
pathy may arise from enhanced EpCAM cleavage induced by
dysregulated matriptase due to insufﬁcient HAI-2 function, as
suggested in a recent in vitro study by Wu et al.17.
Spint2 knockout mice are embryonic lethal, and show
embryonic ectoderm clefting, defects in neural tube closure, and
impaired development of the placental labyrinth12. However,
there are few reports that analyzed the in vivo molecular func-
tions of HAI-2/Hai-2. Szabo et al.18 showed that crossbreeding
Spint2 null mice with Prss8 (also known as prostasin) hypo-
morphic mutant mice rescued the embryonic lethal phenotype
associated with Spint2 deﬁciency19. Analysis of intestinal epi-
thelium of double mutant neonates indicated that Hai-2 loss
results in abnormal localization and activation of matriptase
through Prss8 dysregulation4. Those neonates shows histological
changes of the intestine reminiscent to CTE and die within 4 to
7 days after birth19. However, the Spint2-Prss8 double mutant
mouse model is insufﬁcient for use in studies to clarify the role of
Hai-2 in normal homeostasis and disease in vivo when wild-type
Prss8 is present. Therefore, a conditional knockout mouse system
for Spint2 is required to analyze the in vivo physiological and
pathophysiological roles of HAI-2/Hai-2 in detail.
In this report we describe the generation of a conditional
Spint2 knockout mouse model based on the Cre recombinase and
LoxP system. Using a tamoxifen-inducible Cre recombinase
(CreERT2) expression system, we examined the effect of spon-
taneous Spint2 deletion on mice 6 weeks after birth. We found
that Hai-2 is an essential protease inhibitor for epithelial integrity,
Epcam homeostasis and mucosal organization of the intestinal
tract.
Results
Lethal effect of spontaneous Hai-2 loss in mice. To circumvent
the embryonic lethality associated with Hai-2 deﬁciency, we
engineered mice homozygous for Spint2 ﬂoxed alleles in which
Cre recombinase expression results in the deletion of most of the
Spint2 gene coding region, including exons encoding KD1
(exon 2) and KD2 (exon 5) (Fig. 1a and Supplementary Fig. 1a).
The ﬂoxed mice were then crossed with ROSA26-CreERT2 mice
to generate Spint2LoxP/LoxPCreERT2 mice. We then analyzed the
effects of Spint2 deletion following intraperitoneal administration
of tamoxifen to Spint2LoxP/LoxPCreERT2 mice (homozygous
Spint2 deletion) at 6 weeks of age to activate the Cre recombinase
and compared the induced phenotypes with those of vehicle-
treated controls (wild-type Spint2) and also with tamoxifen-
treated Spint2LoxP/+CreERT2 mice (heterozygous Spint2
deletion). Within three days, tamoxifen-treated Spint2LoxP/LoxP-
CreERT2 mice were lethargic and had signiﬁcant weight loss
(Fig. 1b). Three days after starting tamoxifen treatment, Hai-2
mRNA was hardly detectable in major Hai-2-expressing organs
such as the intestinal tract (Fig. 1c). Genomic polymerase chain
reaction (PCR) conﬁrmed the DNA rearrangement in all tissues
except for the brain (Supplementary Fig. 1b). Notably, the Spin-
t2LoxP/LoxPCreERT2 mice survived no more than 6 days after
beginning tamoxifen treatment, indicating that the induced loss
of Hai-2 protein had a lethal effect (Fig. 1d). Similar results were
seen for another Spint2LoxP/LoxP mouse line derived from an
independently targeted embryonic stem (ES) clone (ES89; Sup-
plementary Table 1).
Hai-2 loss induced severe epithelial damage of the intestine. To
clarify the cause of lethality in Spint2LoxP/LoxPCreERT2 mice, we
sacriﬁced the mice 24, 36, 48, and 72 h after starting tamoxifen
treatment. At 72 h, macroscopic phenotypes were observed in the
gastrointestinal tracts of tamoxifen-treated Spint2LoxP/LoxP-
CreERT2 mice, but not in other organs. In the treated mice, the
length of the intestine was shorter compared to the control mice
and the tissue showed diffuse mucosal damage. The stomach was
expanded (Fig. 2a). Subsequent histopathological evaluation
revealed successful ablation of the Hai-2 protein and diffuse
epithelial damage with mucosal disorganization throughout the
intestinal tracts of Spint2LoxP/LoxPCreERT2 mice. In the small
intestine, 72 h after starting the tamoxifen treatment Spint2
inactivation dramatically altered the mucosal architecture as
evidenced by severe villus atrophy and signiﬁcantly elongated
crypts that showed proliferative activity (Fig. 2b). The ratio of
villous length relative to the corresponding crypt depth was sig-
niﬁcantly decreased in tamoxifen-treated mice relative to vehicle-
treated control mice (p= 0.0005) (Supplementary Fig. 2a). In the
villous epithelium, stacking of enterocyte nuclei produced a tufted
appearance compatible with descriptions of intestinal specimens
from CTE patients (Fig. 2b)15,16. The time-course observation
also indicated that the number of enterocytes positive for cleaved
caspase-3 increased in the upper portion of the crypts and villus
base 36 h after tamoxifen treatment (Supplementary Fig. 2b).
After 48 h, increased exfoliation of single epithelial cells was
present, with peeling of enterocyte sheets from the villous tip
(Fig. 2c). These peeling cells were positive for staining with
antibodies against cleaved caspase-3 and single-strand DNA
(ssDNA), suggestive of apoptotic changes (Fig. 2c). Meanwhile,
the number of Paneth cells decreased in the crypt base (Fig. 2d) in
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a statistically signiﬁcant level (p= 0.0028, Student t-test, Sup-
plementary Fig. 2c).
Diffuse epithelial damage was also evident in the large
intestine. Both the cecum and colon showed obvious, diffuse
epithelial damage 36 h after treatment, with increased numbers of
apoptotic bodies and exfoliating cells (Fig. 3a). The number of
crypts was decreased by 48 h, followed by an active regeneration
phase when elongated crypts became apparent. After 72 h,
mucosal disorganization was evident, showing marked mucosal
thickening with elongated crypts, reactive epithelial cell atypia,
and small tufted structures consisting of stacked enterocytes on
the surface (Fig. 3a, b). The elongated crypts were composed
mostly of Ki67-positive proliferating cells, and many detached
cells having pyknotic nuclei were also present (Fig. 3b). The
number of goblet cells showed a time-dependent decrease after
tamoxifen treatment (Fig. 3c). Collectively, the absence of Hai-2
proteins impaired the terminal differentiation capacity needed to
establish a normal epithelial structure. However, no increase in
the frequency of β-catenin nuclear translocation was observed
during the observation period, indicating that abnormal Wnt/β-
catenin signaling did not contribute to the Hai-2 loss-induced
enteropathy (Supplementary Fig. 2d).
Although the glandular epithelium of the stomach also showed
slightly increased amounts of apoptosis and focal erosion, these
changes were not as pronounced as those seen in the intestine
(Supplementary Fig. 3). Thus, the marked stomach distention was
likely secondary to intestinal dysfunction. Taken together, the
marked structural damages and dysfunction of the intestinal
epithelium likely underpin the lethality caused by spontaneous
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Fig. 1 Generation of conditional Spint2 knockout mice and effect of spontaneous Hai-2 loss on survival. a Schematic representation of the Spint2 gene,
targeting vector, ﬂoxed Spint2 gene, and ﬂoxed Spint2 gene after Cre-mediated recombination. The recombination results in excision of exons 2 to 6. M,
MfeI site; B, BamHI site. 1 and 2: Southern probe. Positions of PCR primers P1, P2, and P3 for genotyping and P4 and P5 for RT-PCR are also shown. b The
effect of Spint2 deletion on body weight gain in mice. Six-week-old male mice were treated with tamoxifen in corn oil (Tam) or corn oil alone (vehicle) for
3 days. Arrows indicate treatment points. The number of mice in each group is also indicated (n). Data are mean ± standard error (SE). p-value; two-way
repeated-measures ANOVA. c Representative RT-PCR for Hai-2 mRNA in Spint2LoxP/LoxPCre-ERT2 mice given a daily intraperitoneal injection of Tam or
vehicle for 3 days. Arrowhead and arrow indicate major Hai-2 isoform of mice carrying only KD2 and the minor isoform including both KD1 and KD2,
respectively27. 1, brain; 2, thymus; 3, lungs; 4, liver; 5, spleen; 6, kidneys; 7, forestomach; 8, glandular stomach; 9, jejunum; 10, ileum; 11, small intestinal
mucosa; 12, cecum; 13, colon. d Effect of Spint2 deletion on survival. Six-week-old male mice were treated with Tam or vehicle for 3 days. Arrows
indicate treatment points. The mice were observed every 12 h and survival was plotted for each Spint2LoxP/LoxP mouse treated with Tam (i.e., wild-type
Spint2), Spint2LoxP/LoxPCreERT2 treated with vehicle only (wild-type Spint2), Spint2LoxP/+CreERT2 treated with Tam (Spint2 heterozygous deletion), or
Spint2LoxP/LoxPCreERT2 treated with Tam (Spint2 homozygous deletion). The number of mice in each group is also indicated (n)
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Extrahepatic biliary tracts were also affected by Hai-2 loss. As
HAI-2/Hai-2 is widely expressed in epithelial tissues in humans
and mice1,2,20, we also searched for additional histopathological
changes in other epithelial tissues. Signiﬁcant alterations were
observed in the epithelium of the gallbladder and extrahepatic
bile duct of Spint2LoxP/LoxPCreERT2 mice. The gallbladder epi-
thelial cells tended to have a hobnail appearance, occasionally
forming a slight tufted structure and increased exfoliation
(Fig. 4a). However, apoptotic bodies were not evident compared
with that seen in the intestinal epithelium. Although the epithe-
lium of the extrahepatic biliary tract showed similar changes, the
intrahepatic small bile ducts and pancreatic duct were not notably
affected by Hai-2 ablation (Fig. 4b and Supplementary Fig. 3). In
accordance with this observation, Hai-2 expression levels were
lower in the intrahepatic small bile ducts and pancreatic ducts
compared with the epithelia of gallbladder and extrahepatic bile
duct (Fig. 4). The skin, bronchopulmonary epithelial cells, eso-
phageal epithelium, and renal tubules showed no obvious
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Fig. 2 Effects of Spint2 deletion on the gastrointestinal tract. a Decreased intestinal length in Spint2-deleted mice. Representative macroscopic photos of
gastrointestinal tissue (left; bars, 2 cm) and box plots of intestinal length (right) are shown. 1, Spint2LoxP/LoxP mice treated with tamoxifen (Tam); 2,
Spint2LoxP/LoxPCreERT2 mice treated with corn oil only (vehicle); 3, Spint2LoxP/+CreERT2 mice treated with Tam; 4, Spint2LoxP/LoxPCreERT2 mice treated
with Tam. The 25th and 75th percentile (boxes) and the median (bold line within the boxes) are plotted. Circle represents the value of each case. N= 8 for
each group. p-value; Mann–Whitney U-test. b Histology of small intestine (Spint2LoxP/LoxPCreERT2 mice) tissue 72 h after tamoxifen or vehicle treatment.
Representative photos of HE-stained sections from the proximal small intestine of the vehicle-treated mouse (upper panel, left), proximal small intestine of
the tamoxifen-treated mouse (center) and distal small intestine of the tamoxifen-treated mouse (right) are shown. Arrow indicates a tuft formed by
enterocytes. Photos of Hai-2 and Ki67 immunohistochemistry are also shown in the lower panel. Bars, 50 μm. c Detachment of surface epithelial sheets
observed 48 h after tamoxifen treatment. Representative photos of HE-stained and cleaved caspase-3 (cCas3)-stained section from the proximal small
intestine (left panel) are shown. Distal small intestine showed similar change and the cells were also immunohistochemically positive for ssDNA (right
upper panel). At 72 h after tamoxifen treatment, villi were shortened with many cCas3-positive cells in the upper portion and increased numbers of
apoptotic bodies in the crypts (proximal small intestine; right lower panel). Bars, 50 μm. d Decreased numbers of Paneth cells in the small intestine. HE
staining and immunohistochemical staining for lysozyme are shown. Bars, 50 μm
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Fig. 3 Effects of Hai-2 ablation on large intestine. a Histology of the cecum from Spint2LoxP/LoxPCreERT2 mice after tamoxifen or vehicle (corn oil)
treatment. Representative photos of HE from mice 24, 36, and 72 h after tamoxifen treatment are shown. Successful Hai-2 ablation was conﬁrmed by
immunohistochemistry. b Histology of the colon 72 h after tamoxifen treatment. Crypts were elongated with many exfoliating, degenerated cells present in
the lumen. Arrows indicate a tuft formed by enterocytes. Higher magniﬁcation images are shown in the insets. Representative photos of Ki67
immunohistochemistry are also presented (right panel). c Decreased numbers of goblet cell in Spint2-deleted colon mucosa. Alcian-blue staining. The 25th
and 75th percentile (boxes) and the median (bold line within the boxes) are plotted. Circle represents the value of each case. Goblet cells per crypt of
Spint2-deleted mice (n= 5 and 11 for 48 h and 72 h after starting treatment, respectively) in the proximal and distal colon were counted and compared to
that for vehicle-treated control mice (n= 8). p-value; Mann–Whitney U-test. Bars, 50 μm (a–c)
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histopathological changes during the observation period (Sup-
plementary Fig. 3).
Hai-2 loss led to destruction of intestinal organoids. Epithelial
damage and disorganization of the intestinal architecture in
Spint2-deleted mice could be a direct effect of Hai-2 loss in epi-
thelial cells or arise from secondary stromal inﬂammation caused
by leaky epithelia and intestinal microbial colonization. To dis-
tinguish between these possibilities, we performed in vitro three-
dimensional (3-D) crypt organoid culture of Spint2LoxP/
LoxPCreERT2 small intestine cells. Similar to in vivo observations,
deterioration of organoid integrity began 24–28 h after treatment
with 4-hydroxytamoxifen (4-OHT) (Fig. 5a and Supplementary
Movies 1 and 2). At 36 h (Fig. 5b), destruction or rupture of crypt
structure was apparent (Supplementary Movies 1 and 2), whereas
the vehicle-treated organoids were intact (Supplementary
Movie 3).
Disruption of Epcam/claudin-7 complex by Hai-2 loss. CSD
patients, including those with syndromic-form CSD caused by
SPINT2 mutation, show intestinal histology compatible with that
observed in CTE caused by EPCAM mutations. Therefore, we
performed immunohistochemical analysis of the expression and
localization of Epcam and one of its essential partners in the
intestinal epithelium, claudin-721,22. Hai-2-deﬁcient epithelium
showed decreased cell surface Epcam immunoreactivity and
mislocalization within the cytoplasm of disorganized epithelial
cells, particularly in cells forming tufts, as well as accompanying
decreases in claudin-7 immunoreactivity (Fig. 6a). The disruption
and mislocalization of Epcam peaked 48 h after tamoxifen
treatment, as did increases in mucosal permeability (Fig. 6b, c).
Loss of cell surface Epcam and claudin-7 immunoreactivity was
also observed in Hai-2-deﬁcient extrahepatic biliary epithelium
(Fig. 6d).
We then analyzed Epcam and claudin-7 expression in 3-D
intestinal organoid cultures from Spint2LoxP/LoxPCreERT2 mice.
Immunoblot analysis showed enhanced levels of a 35-kDa
cleavage product of Epcam in the absence of Hai-2 as well as
markedly decreased claudin-7 levels (Fig. 7a). Immunoﬂuores-
cence analysis of these proteins also showed signiﬁcantly
decreased cell surface Epcam and claudin-7 in organoids after
4-OHT treatment (Fig. 7a). On the other hand, Epcam and
claudin-7 mRNA levels were not affected (Supplementary Fig. 4),
a
Vehicle 72 h Tam 72 h Vehicle 72 h Hai-2
Tam 72 h Hai-2
Tam 72 h Tam 72 hTam 72 h
Hepatocytes and portal tract Extrahepatic bile duct Gallbladder
b
Vehicle 72 h Vehicle 72 h Vehicle 72 h
Hai-2Hai-2
Fig. 4 Histology of biliary tracts of Spint2LoxP/LoxPCreERT2 mice 72 h after tamoxifen or vehicle (corn oil) treatment. a Histology of interlobular small bile
duct (left panel), extrahepatic bile duct (center) or gallbladder (right). Hai-2 ablation resulted in severe morphological alterations of the extrahepatic biliary
epithelium. Arrow indicates erosion observed in Hai-2-deﬁcient bile duct mucosa. Higher magniﬁcation photos of Hai-2 immunohistochemistry of bile
ducts from vehicle-treated mice are also shown. Bars, 50 μm. b Higher magniﬁcation of gallbladder epithelium. Arrows and arrowhead indicate epithelial
tufts and exfoliating cells, respectively. Representative images of Hai-2 immunohistochemistry are also shown. Bars, 50 μm
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indicating that the decrease in cell surface Epcam and claudin-7
in response to Spint2-deletion occurred at a post-translational
level. Importantly, addition of the protease inhibitor aprotinin to
the culture media signiﬁcantly suppressed Epcam cleavage and
concomitant decreases in claudin-7 levels (Fig. 7a). Therefore, an
excess of trypsin-like serine protease activity was likely respon-
sible for Epcam cleavage. Notably, aprotinin rescued Hai-2
ablation-induced destruction in organoids (Fig. 7b). Similar
in vitro results were also obtained following the addition of the
synthetic serine protease inhibitor camostat mesilate (Fig. 7c).
However, in vivo administration of camostat mesilate (oral or
intraperitoneal) could not rescue the lethal phenotype of
Spint2LoxP/LoxPCreERT2 mice after tamoxifen treatment (Supple-
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Vehicle 36 h 4-OHT 36 h
b
Vehicle 28 h 4-OHT 28 h
Fig. 5 Organoid crypt culture of small intestine from Spint2LoxP/LoxPCreERT2 mice treated with (4-OHT) or without (vehicle) 1 μM 4-OHT. a Representative
photos of phase-contrast microscopy of time-course for changes of organoids treated with 1 μM 4-OHT (two independent experiments) or vehicle
(ethanol) only. b HE staining of organoids 28 h (upper panel) and 36 h (lower panel) after treatment. Arrows indicate Paneth cells. Bars, 50 μm
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may be due to insufﬁcient concentration of the inhibitor in the
intestinal microenvironment in vivo, which will require further
studies.
There were no signiﬁcant changes in the expression of other
junctional proteins, including E-cadherin, claudin-2 and ZO-1 in
response to Hai-2 ablation (Fig. 7d). Taken together, these results
indicate that Hai-2 is an essential cellular protease inhibitor
needed to stabilize the Epcam/claudin-7 complex in the intestine.
Prss8 was required for Epcam cleavage in Spint2−/− organoids.
In mouse studies, embryonic lethality of Spint2−/− mice could be
prevented by reducing Prss8 (prostasin) activity4,18,19. In the
human intestinal epithelial cell line Caco2, HAI-2 regulates
PRSS8, which is required for normal cell surface localization and
function of matriptase4,23. Moreover, in these cells, HAI-2
insufﬁciency leads to enhanced EpCAM cleavage by matrip-
tase17. These lines of evidence suggest that phenotypes induced by
spontaneous ablation of Hai-2 may be secondary to dysregulation
of the Prss8-matriptase axis. To explore this possibility, we
crossed Spint2LoxP/+CreERT2 mice with Prss8LoxP/+ mice to
generate either Spint2LoxP/LoxPPrss8LoxP/+CreERT2, Spint2LoxP/+
Prss8LoxP/LoxPCreERT2 or Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2
mice, which were treated with tamoxifen at 6 weeks of age. The
mean body weight of Spint2LoxP/+Prss8LoxP/LoxPCreERT2 mice
did not decrease after tamoxifen treatment (Fig. 8a), suggesting
that Prss8 is not essential for maintenance of the intestinal epi-
thelium as reported previously24. Deletion of Prss8 gene did not
rescue the lethal phenotype caused by postnatal deletion of
Spint2. After tamoxifen treatment, the body weight loss of
Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 mice was comparable to
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Fig. 6 Disruption of Epcam and claudin-7 after Hai-2 ablation and increased mucosal permeability in vivo. a Immunohistochemical analysis of Epcam and
claudin-7 in the jejunum (villus portion) and cecum 48 h after tamoxifen (Tam) treatment in Spint2LoxP/LoxPCreERT2 mice. Epithelial cell surface
localization of Epcam and claudin-7 was severely disrupted by Spint2 deletion. b Immunohistochemical analysis of Epcam in the cecum 24, 48, and 72 h
after tamoxifen treatment. c Mucosal permeability in Spint2LoxP/LoxPCreERT2 mice 48 h after vehicle (corn oil) (n, 3) and tamoxifen (n, 4) treatment. The
25th and 75th percentile (boxes) and the median (bold line within the boxes) are plotted. Circle represents the value of each case. *p= 0.00034 (Student
t-test). d Immunohistochemical analysis of Epcam and claudin-7 in the gallbladder epithelium 72 h after vehicle or tamoxifen (Tam) treatment in
Spint2LoxP/LoxPCreERT2 mice. Bars, 50 μm (a, b, and d)
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(Fig. 8a) and the intestinal tissues showed similar macroscopic
changes (Fig. 8b). We next sought to determine whether Prss8
is required for Epcam cleavage in the presence of Hai-2
ablation in organoids prepared from the small intestines of
Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 mice. In contrast to the
observation in vivo, co-deletion of Prss8 suppressed Epcam
cleavage, stabilized claudin-7 levels (Fig. 8c, d) and rescued
destruction of crypt organoids caused by Hai-2 ablation (Fig. 8e).
Matriptase cleaved Epcam in Spint2−/− organoids. It has been
reported that Prss8 cannot directly cleave Epcam whereas
matriptase can17. Thus, we asked whether matriptase was
responsible for the enhanced cleavage of Epcam in Spint2-deleted
intestinal organoids due to dysregulated Prss8-matriptase axis.
Transfection of matriptase short hairpin RNA (shRNA) lentiviral
vector reduced the matriptase mRNA level by 56%, which partly
alleviated the Epcam cleavage in Spint2-deleted organoids
(Fig. 9a, b). In accordance with this observation, matriptase-
selective synthetic inhibitor ZFH7185-8 suppressed the Hai-2
loss-induced Epcam cleavage in a dose-dependent manner,
accompanying stabilization of claudin-7 (Fig. 9c). In contrast,
hepsin-selective inhibitor ZFH7185-3 did not show notable
effects (Fig. 9c).
Discussion
In this study, we demonstrated that acute ablation of the Hai-2
protein had a lethal effect on mice due to epithelial changes and
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Fig. 7 Enhanced cleavage of Epcam in response to Hai-2 ablation. a Immunoblot analysis of Epcam and claudin-7 in intestinal organoids from
Spint2LoxP/LoxPCreERT2 mice. Organoids were treated with 4-OHT (1 μM) or vehicle only (ethanol) for the indicated time with or without aprotinin
(200 μg/mL). 4-OHT-induced ablation of Hai-2 resulted in Epcam cleavage accompanied by signiﬁcantly decreased intensity of claudin-7 bands; this effect
was rescued completely by aprotinin. The 25th and 75th percentile (boxes) and the median (bold line within the boxes) are plotted. Circle represents the
value of each case. p-value; Student t-test. b Effect of aprotinin (200 μg/mL) on Hai-2 ablation-induced organoid destruction (28 h after 4-OHT
treatment). c Dose-dependent effects of camostat mesilate on Epcam cleavage 24 h after 4-OHT treatment. d Effects of Hai-2 ablation on E-cadherin,
claudin-2 (immunoblot, left panel) and ZO-1 (immunoﬂuorescence, right panel)
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cells and in turn active cellular proliferation occurred in the
intestinal crypts, epithelial regeneration was abnormal such that
the intestinal mucosa eventually showed severely disorganized
architecture, atrophic villi, continuous exfoliation and tufted
formations composed of enterocytes, as well as markedly elon-
gated crypts. Mice carrying the Spint2 deletion all died within
6 days of initiating tamoxifen treatment.
Congenital SPINT2 mutations induce a syndromic form of
CSD, and the intestinal epithelium of patients suffering from this
rare autosomal-recessive disorder shows histological changes
similar to those seen in CTE15,16. Conventional CTE is caused by a
mutation in the EPCAM gene wherein abnormal EpCAM function
destabilizes EpCAM-associated claudin-7, which eventually results
in abnormally enhanced epithelial permeability15,21,22,25. Our
organoid culture study revealed that Hai-2 loss accelerates Epcam
protein cleavage, which was suppressed by the addition of protease
inhibitors targeting trypsin-like serine proteases. Therefore, excess
cleavage of Epcam by serine proteases could occur in the absence
of Hai-2. Evidence indicates that HAI-2/Hai-2 regulates PRSS8/
Prss8 in epithelial cells such as enterocytes, which inﬂuences
Spint2LoxP/LoxPPRSS8LoxP/LoxPCreERT2 + Tam (n, 5)
Spint2LoxP/LoxPPRSS8LoxP/+CreERT2 + Tam (n, 5)
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matriptase localization and activation in the cells4,5,10,23. Given
that EpCAM is a matriptase substrate in human enterocytes17,
abnormal activity of the Prss8-matriptase axis could underpin the
enhanced Epcam cleavage that occurred in the absence of Hai-2.
Indeed, co-deletion of Prss8 and Spint2 in organoids relieved the
Epcam cleavage in the absence of Hai-2, and consequently
maintained the claudin-7 levels and rescued organoids from
subsequent rupture. Moreover, silencing of matriptase in orga-
noids or treatment of the organoids with matriptase-selective
synthetic inhibitor alleviated the Hai-2 loss-induced Epcam clea-
vage. Therefore, Hai-2 tightly regulates Prss8-matriptase axis in
the intestinal epithelial cells and dysregulation of this axis results
in excess Epcam cleavage by matriptase and destabilization of the
Epcam/claudin-7 complex.
Whereas co-deletion of Prss8 and Spint2 suppressed Epcam
cleavage caused by Spint2 deletion in organoids, Spint2/Prss8 co-
deletion could not rescue the lethal phenotype associated with
Spint2 deletion in mice. This discrepancy may be consistent with
recent observations in another CTE model: Spint2−/−Prss8R44Q/
R44Q double mutant mice19. In the double mutant model,
homozygous R44Q mutation of Prss8 gene resulted in the
impaired activation of prostasin zymogen (i.e., zymogen-locked
Prss8) and rescued embryonic lethality caused by the Spint2
deletion, and the intestinal development was normal in
Spint2−/−Prss8R44Q/R44Q fetus at E18.519. However, after birth,
Spint2−/−Prss8R44Q/R44Q mice showed severe growth retardation
and died within a week with severe intestinal abnormalities
reminiscence to CTE19. Thus, homozygous R44Q mutation in
Prss8 rescued Spint2 deletion-induced CTE only during the fetal
period. Environmental factors, such as intestinal microbial colo-
nization and food intake, may underpin the conﬂicting observa-
tions between mice in vivo after birth and organoids ex vivo that
might be equivalent to the fetal intestine. Nonetheless, these lines
of evidence raise the question of whether Epcam cleavage is
sufﬁcient to induce the severe intestinal phenotype in vivo. In
fact, the histological abnormalities observed in the colon mucosa
of the Spint2-deletion mice in this study were more severe than
those reported for Epcam mutant mice21,22. Moreover, our Spint2
knockout mice showed epithelial abnormalities in the gallbladder
and extrahepatic bile duct, which were not reported in the Epcam
knockout studies21,25. Therefore, the role of Hai-2 in epithelial
cells may not be limited to stabilization of the Epcam/claudin-7
complex in the intestine, and Hai-2 may have additional, vital
functions for epithelial cells in vivo. HAI-2/Hai-2 immunor-
eactivity has been observed primarily in the cytoplasm1,8,10, and it
likely localizes to the endoplasmic reticulum (ER)9. HAI-2/Hai-2
may therefore have an important role in regulation of proteolysis
in ER and intracellular secretory pathways, which might be
required to maintain epithelial integrity in vivo. Further studies to
identify proteins interacting with HAI-2/Hai-2 will be required.
Whether Hai-2 loss affects the activity of epithelial sodium
channel (ENaC) also remains unclear. Prss8 and matriptase,
which are both Hai-2 sensitive, are likely involved in ENaC
activation3,24, and patients carrying SPINT2 gene mutations often
experience sodium diarrhea. Although the severe effect of spon-
taneous Hai-2 ablation precluded analysis of ENaC function in
our mouse model in vivo, ex vivo intestinal organoids from these
mutant mice could provide a tool for future studies to explore
the roles of Hai-2 and Prss8 in intestinal ENaC activation. Finally,
the effect of Hai-2 loss on intestinal stem cells also awaits analysis.
Given that the number of Lgr5-positive intestinal stem cells
remained unchanged in Epcam-deleted mice21, intestinal stem
cells may not be a primary target in the Spint2 deletion-induced
phenotype. However, Paneth cells maintain the stem cell niche in
intestinal crypts26, and the number of Paneth cells was decreased
by Spint2 deletion. Therefore, the maintenance of stem cells may
indeed be disturbed in the Spint2-deleted intestine.
The conditional Spint2 knockout mouse described in this
report is the second mouse model of Hai-2 deﬁciency-induced
CTE next to Spint2−/−Prss8R44Q/R44Q double mutant mouse
recently reported by Szabo and Bugge19. Although both models
show similar CTE morphology, there are a couple of differences
in regard to histological ﬁndings. First, mucosal damage,
inﬂammation and apoptotic epithelial cells were more evident in
our model compared to the double mutant model. Second, Ki67-
positive cells in the intestinal crypts increased signiﬁcantly in our
model, but not in the double mutant model. In addition,
abnormalities observed in the extrahepatic biliary epithelium of
our mutant mice were not reported in the double mutant mice19.
These differences may be due to the method of Spint2 ablation:
acute Spint2 ablation in postnatal period in our model versus
genetically Spint2 null condition in the double mutant model. The
strength of the Spint2-Prss8 double mutant model may be an
early-onset intestinal failure after birth, which likely mimics the
patients of congenital CTE19. However, Prss8 mutation is not
reported in the CTE patients. The current conditional Spint2
knockout mouse model has wild-type Prss8 and has an advantage
in this regard. Another important advantage of the current model
is the availability of organoid culture. The intestinal organoids
from Spint2LoxP/LoxPCreERT2 mice reproduces molecular chan-
ges induced by Hai-2 deﬁciency in vitro, providing an indis-
pensable research tool for the study of CTE.
In conclusion, Hai-2 is a vital epithelial protease inhibitor that
is needed to maintain the integrity of the intestine and extra-
hepatic biliary epithelia as well as to stabilize the Epcam/claudin-
7 complex. Our Spint2-mutant mouse model together with the
intestinal organoid culture from these mutant mice would pro-
vide a useful tool for detailed studies of HAI-2/Hai-2 function in
epithelial cells and the screening of therapeutic compounds for
patients carrying SPINT2 mutations. Successful inhibition of
Fig. 8 Effect of Prss8 co-deletion on spontaneous Spint2 deletion-induced phenotype in mice. a The effect of tamoxifen-induced Prss8 co-deletion on body
weight gain in mice with homozygous or heterozygous Spint2 deletion. Six-week-old male mice were treated with tamoxifen (Tam) or vehicle for 3 days.
Arrows indicate treatment points. The number of mice in each group is also indicated (n). Data are mean ± SE. *p < 0.0001 (two-way repeated-measures
ANOVA). Representative results of genotyping of small intestine 72 h after starting Tam treatment are also shown. b Effect of Prss8 co-deletion on cecum
and colon length 72 h after tamoxifen treatment. 1, Spint2LoxP/LoxP (n, 8); 2, Spint2LoxP/LoxPCreERT2 (n, 8); 3, Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 (n, 5); 4,
Spint2LoxP/LoxPPrss8LoxP/+CreERT2 (n, 5); 5, Spint2LoxP/+Prss8LoxP/LoxPCreERT2 (n, 5). Box plots are shown and the median is indicated by a bold vertical
line. Circle represents the value of each case. p-value: Student t-test. The data for 1 and 2 are from Fig. 2a. Genotypes of each group after tamoxifen
treatment are also indicated. c Time-course of Epcam cleavage and claudin-7 band intensity of organoids from Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 mice
and littermate Spint2LoxP/LoxPCreERT2 mice. Hai-2 ablation-induced Epcam cleavage and claudin-7 loss were alleviated by Prss8 ablation. Data of
genotyping at 28 h after starting 4-OHT treatment (1 μM) are indicated in the right panel. d Time-course quantitative analysis of Epcam cleavage and
claudin-7 levels after 4-OHT (1 μM) treatment of the organoids from Spint2LoxP/LoxPCreERT2 (ﬂoxedSpint2) and Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2
(ﬂoxedSpint2/ﬂoxedPrss8) mice. Data are mean ± SE. p-value: Student t-test, n= 3. e Time-course morphology of organoids from organoid of small
intestine from Spint2LoxP/LoxPCreERT2 or Spint2LoxP/LoxPPrss8LoxP/LoxPCreERT2 mice treated with or without (vehicle) 1 μM 4-OHT
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Hai-2 loss-induced Epcam cleavage by an exogenous serine
protease inhibitor in an ex vivo organoid culture model could be
important for developing treatments for intestinal failure induced
by Spint2 mutations.
Methods
Antibodies. The following anti-mouse antibodies were used: anti-Hai-2 goat
polyclonal antibody (pAb) (R & D Systems, Minneapolis, MN); anti-Epcam
(ProteinTech., Rosemont, IL), anti-claudin-7 (Thermo Fisher Scientiﬁc, Waltham,
MA), anti-mouse β-catenin (Sigma, St. Louis, MO), anti-cleaved caspase-3 (Cell
Signaling, Boston, MA), and anti-lysozyme (AVIVA Systems Biology, San Diego,
CA) rabbit pAbs; anti-Ki67 rabbit monoclonal antibody (mAb) (Abcam, Cam-
bridge, UK); anti-E-cadherin goat pAb (R & D Systems); anti-claudin-2 and anti-
ZO-1 rabbit pAbs (Thermo Fisher Scientiﬁc); anti-β-actin mouse mAb (Sigma) and
anti-ssDNA rabbit pAb (Dako, Carpinteria, CA).
Generation of Spint2 conditional knockout mice. All of the animal work was
performed under the approval of the University of Miyazaki Animal Research
Committee, in accordance with international guidelines for biomedical research
involving animals. The required portions of the mouse Spint2 gene were ampliﬁed
by PCR from a mouse (C57BL/6) genomic bacterial artiﬁcial chromosome library
and subcloned into a pBluescript II SK+ phagemid vector (Agilent Technologies,
Palo Alto, CA), which was used to construct a targeting vector. LoxP sites were
inserted into exons 2 and 6 to delete all transcript variants of the Spint2 gene27,28
following activation of Cre recombinase. A neomycin resistance gene (neo) cassette
for positive selection was inserted into intron 6 and was ﬂanked by short ﬂippase
recognition target (FRT) sites. The targeting vector also contained a diphtheria
toxin expression cassette for negative selection and had an MfeI site for screening
by Southern blotting. The targeting vector was linearized with SacII and transfected
into C57BL/6 strain ES cells by electroporation. Correctly targeted ES clones were
selected using G418 (Sigma). Two independently targeted ES clones (ES16 and
ES89) were obtained and microinjected into morulae of ICR mice. The resulting
chimeras were mated with C57BL/6 mice. Germline transmission of the targeted
allele was detected by progeny coat color and PCR. FLPeR mice29 were purchased
from The Jackson Laboratory (Bar Harbor, ME) and the mutant mice were cross-
mated for more than nine generations with C57BL/6 mice (Charles River
Laboratories, Portage, MI). Then, Spint2LoxP/+/neo+mice were crossed to the B6-
background FLPeR mice to remove the neo cassette. Heterozygous offspring
(Spint2LoxP/+) were crossed to produce homozygous mutant offspring (Spint2LoxP/
LoxP). Spint2LoxP/LoxP mice were further crossed with ROSA26-CreERT2 mice (The
Jackson Laboratory) to generate ROSA26-CreERT2 mice with the ﬂoxed Spint2





































































































Fig. 9 Matriptase is responsible for Epcam cleavage. a Knockdown efﬁcacy of matriptase (encoded by St14 gene) shRNA in organoids from
Spint2LoxP/LoxPCreERT2 mice. RNA was extracted from mock-transfected control (cont) and matriptase shRNA lentivirus vector-transfected (KD)
organoids and matriptase mRNA levels were veriﬁed by quantitative RT-PCR. The 25th and 75th percentile (boxes) and the median (bold line within the
boxes) are plotted. Circle represents the value of each measurement. *p= 0.029 (Student t-test; n, 4). b Control and matriptase-knockdown organoids
were treated with 4-OHT (1 μM) or vehicle only (ethanol) for 28 h. Immunoblot analysis of Epcam and claudin-7 (left panel) and representative
morphology of organoids (right panel) are shown. c Dose-dependent effects of matriptase-selective inhibitor (ZFH7185-8) on Epcam cleavage and claudin-
7 in Spint2LoxP/LoxPCreERT2 organoids with or without 4-OHT treatment (28 h). Hepsin-selective inhibitor (ZFH7185-3) was also used as a control (lower
panel). Representative photos of organoids are also shown
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week-old male mice were treated by intraperitoneal injection of 50 mg (135 μmol)/
kg tamoxifen (Sigma) dissolved in corn oil for 3 consecutive days. Successful DNA
rearrangement and loss of Spint2 mRNA were validated by genomic PCR and
revere-transcription (RT)-PCR using DNA and total RNA, respectively, extracted
from the tissues. The primers used for the validation described above are shown in
Supplementary Fig. 1 and Supplementary Table 2. The site of each primer for
genomic PCR is indicated in Fig. 1a. Unless otherwise indicated, data from the
ES16 mouse line are presented.
To generate Spint2 and Prss8 double conditional knockout mice,
Spint2LoxP/+CreERT2 mice were crossed with Prss8LoxP/+mice30. Primer sequences for
genotyping of the Prss8 mutant mice are shown in Supplementary Table 2.
Histological analysis. For histological analysis, mice tissues were ﬁxed in 4%
formaldehyde in phosphate-buffered saline (PBS) and embedded in parafﬁn. Four-
micrometer-thick sections were stained with hematoxylin and eosin (HE). Villus
length and crypt depth were measured using Olympus cellSens imaging software
(v1.15). To count the number of Paneth cells, ten randomly selected areas were
photographed at 200×magniﬁcation from each mouse small intestine. Then, two
independent investigators counted the number of Paneth cells per crypt. To count
the number of goblet cells, large intestinal tissues were stained with alcian-blue, and
ten randomly selected areas were photographed at 200×magniﬁcation from each
mouse. Then, two independent investigators counted the number of goblet cells per
crypt.
Immunohistochemical staining of mouse tissue sections. Mice were sacriﬁced
at the indicated time point, autopsied and tissues were ﬁxed with 4% formaldehyde
in PBS. Immunohistochemistry of formalin-ﬁxed, parafﬁn-embedded tissue sec-
tions was performed as described previously31,32 except for Hai-2 and ssDNA.
Brieﬂy, tissue sections were processed for antigen retrieval by autoclaving for 5 min
at 121 °C in 1 mM EDTA pH 8.0 for cleaved caspase-3 or in 10 mM citrate buffer
pH 6.0 for other antibodies, followed by treatment with 3% H2O2 in PBS for
10 min. After blocking in 3% bovine serum albumin in PBS, the sections were
incubated with primary antibodies for 16 h at 4 °C: anti-Ki-67 (1:100 dilution),
anti-cleaved caspase-3 (1:300 dilution), anti-Lysozyme (1:50 dilution), anti-Epcam
(1:250 dilution), anti-claudin-7 (1:100 dilution), and anti-β-catenin (1:2000 dilu-
tion). After washing with PBS, the sections were incubated with EnvisionTM labeled
polymer reagents (DAKO) for 30 min at room temperature (RT). For anti-Hai-2
pAb (1:250 dilution), Ventana Discovery system (Ventana Medical System,
Tucson, AZ) was used according to the manufacturer’s instructions. For immu-
nostaining of ssDNA, deparafﬁnized tissue sections were incubated with PBS
containing 0.2 mg/mL saponin (Nacalai Tesque, Kyoto, Japan) and 20 μg/mL
Proteinase K (Nacalai Tesque) at RT for 20 min. After washing the slides in dis-
tilled water, sections were heated in preheated 50% formamide in distilled water at
56 °C for 20 min, followed by treatment with 3% hydrogen peroxide for 10 min and
washing in PBS. After blocking in 3% non-fat dry milk for 20 min at 37 °C, the
sections were incubated with anti-ssDNA (1:700 dilution) in 1% non-fat dry milk
at RT for 30 min. The sections were then washed in PBS and incubated with
Envision-labeled polymer reagent (DAKO) for 30 min at RT. The reaction was
revealed with nickel, cobalt-3,3’-diaminobenzidine (Thermo Fisher Scientiﬁc) and
counterstained with hematoxylin.
Intestinal permeability assay. To assess intestinal barrier function, an intestinal
permeability assay was performed as previously described31. Brieﬂy, 250 μg/g body
weight ﬂuorescein isothiocyanate (FITC)-dextran (4 kDa; Sigma) was administered
to the mice by gavage 45 h after starting tamoxifen treatment. Three hours after
administration of FITC-dextran, blood samples were obtained from the right
ventricle, and EDTA-containing plasma samples were collected by centrifugation at
960 × g for 20 min at 4 °C. Plasma (75 μL) was diluted in 250 μL PBS, and ﬂuor-
escence was quantiﬁed using a ﬂuorometer (DTX800 Multimode Detector; Beck-
man Coulter, Fullerton, CA) with excitation and emission wavelengths of 485 and
535 nm, respectively. FITC-dextran concentrations were determined from standard
curves generated by serial dilution of FITC-dextran.
Camostat mesilate administration. Camostat mesilate (Ono Pharmaceutical,
Osaka, Japan) was administered to the mice through addition to the diet or by
gavage, or intraperitoneal injection. For dietary administration, mice were given a
diet containing 0.1% camostat mesilate three days before starting tamoxifen
treatment until termination. For gavage or intraperitoneal injection, mice were
treated with camostat mesilate solution (30 μg/μL water; 200 mg/kg) every 12 h
beginning at the same time as tamoxifen treatment was initiated.
Matriptase-selective synthetic inhibitor. General procedure for the preparation
of α-ketobenzothiazole (kbt) serine protease inhibitors for HGFA, matriptase or
another TTSP namely hepsin has been reported previously33 and described in
Supplementary Methods. Florescent kinetic enzyme inhibitor assays were per-
formed to analyze the selectivity of the kbt inhibitors using either recombinant
catalytic domains of HGFA34, matriptase (#3946-SEB, R&D Systems) or hepsin
(#4776-SE, R&D Systems) in black 384 plates (Corning #3575, Corning, NY)
(Supplementary Methods). Two kbt inhibitors, ZFH7185-8 and -3, were prepared
(Supplemental Methods). ZFH7185-8 is Fmoc-Gly-Arg-kbt that is selective for
matriptase (matriptase Ki, 0.13 nM; hepsin Ki, 831 nM), and ZFH7185-3 is Fmoc-
Asn-Arg-kbt that is selective for hepsin (matriptase Ki, 106 nM; hepsin Ki, 1.7 nM)
(Supplementary Methods).
Intestinal organoid culture. Isolation of intestinal crypts and organoid culture
were performed as described previously35. Brieﬂy, small intestine tissue isolated
from 3- to 4-week-old male mice was washed with cold PBS and minced into 3 mm
pieces. After washing again with cold PBS, the fragments were incubated for 30 min
at 4 °C in PBS containing 2 mM EDTA, followed by centrifugation (400 × g, 3 min).
Then, the fragments were suspended in cold PBS and passed through a 70-μm cell
strainer (BD Biosciences, Bedford, MA). Isolated crypts were collected by cen-
trifugation and further dissociated into single cells by Accumax (Innovative Cell
Technologies, San Diego, CA) treatment for 5 min at 37 °C. For 3-D organoid
culture, the dissociated single cells were resuspended in medium (Advanced
DMEM/F12; Invitrogen, Tokyo, Japan) supplemented with 50 ng/mL EGF
(Peprotech, Rocky Hill, NJ), 500 ng/mL R-Spondin1 (R&D systems), 100 ng/mL
Noggin (Peprotech), 10 μM Y27632 (Wako, Osaka, Japan) and 1 μM Jagged-1
(AnaSpec, San Jose, CA), and seeded on Matrigel (60 μL/well; BD Biosciences) in
12-well plates, which were incubated overnight at 37 °C. After removing ﬂoating
dead cells and medium, viable cells attached to the Matrigel were covered with
80 μL Matrigel and overlaid with complete culture media to resume 3-D culture.
After the organoids formed, they were cultured with or without 1 μM 4-OHT
(Sigma) in the presence or absence of aprotinin (Sigma) or camostat mesilate. To
recover organoids from the Matrigel matrix and prepare sections, BD Cell Recovery
Solution (BD Biosciences) was used according to the manufacturer’s instructions.
Then the organoids were centrifuged (300 × g, 5 min) at 4 °C, formed into gels
using iPGell (GenoStaff, Tokyo Japan) and ﬁxed in 4% paraformaldehyde in PBS
followed by embedding in parafﬁn. Sections (3 μm) were prepared and used for
hematoxylin & eosin (HE) staining and immunostaining.
Analysis of junctional proteins in organoids. Organoids were extracted with
RIPA buffer (Nacalai Tesque) and used for immunoblotting analysis. The mem-
branes were incubated with antibodies against Epcam (1:1000 dilution), claudin-7
(1:1000 dilution), claudin-2 (1:1000 dilution), E-cadherin (1:1000 dilution), and β-
actin (1:1000 dilution) at 4 °C overnight. To detect ZO-1, immunoﬂuorescence
staining was performed as described previously31. Brieﬂy, organoids were ﬁxed
with 4% paraformaldehyde in PBS for 15 min, followed by blocking for 30 min with
5% normal goat serum (Dako) at RT. Then the organoids were incubated with anti-
ZO-1 pAb (1:25 dilution) for 16 h at 4 °C. After washing, the cells were incubated
for 30 min at RT with Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitro-
gen). Then, the organoids were counterstained with 4,’6-diamino-2-phenylindole
(Sigma), and examined with an Axio Imager A2 (Carl Zeiss MicroImaging, Tokyo,
Japan). To validate Epcam and claudin-7 mRNA expression, RT-PCR was per-
formed using total RNA extracted from organoids. Primer sequences are shown in
Supplementary Table 2. Full size immunoblots and gels for all experiments are
shown in Supplementary Fig. 6.
Silencing of matriptase in organoids. For the silencing of matriptase (encoded by
St14 gene) expression, shRNA against St14 was inserted into pLenti4/BLOCK-iT
(Life Technologies Japan). Generation of the lentiviral particles was performed
according to the manufacturer’s instructions. Lentiviral particles were infected as
previously described35. The target sequence was 5′-GCGCTTCAAACTCTTC-
TATCT-3′. To conﬁrm the efﬁciency of St14 gene knockdown, real-time RT-PCR
was performed in a Thermal Cycler Dice Real Time System II (Takara Bio) using
the SYBR Premix Ex Taq II (Takara Bio). The primer sequences are shown in
Supplementary Table 2.
Statistical analysis. Statistical analysis was done using StatView 5.0 (SAS, Cary,
NC, USA). Comparisons between two unpaired groups were done with the
Mann–Whitney U-test, Student’s t-test or two-way repeated-measures analysis of
variance (ANOVA). Signiﬁcance was set at p < 0.05.
Data availability
All data generated or analyzed during this study are included in this published
article and its Supplementary Information ﬁles.
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